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Background
Surgery for spinal stenosis is widely performed, but its effectiveness as compared 
with nonsurgical treatment has not been shown in controlled trials.
Methods
Surgical candidates with a history of at least 12 weeks of symptoms and spinal 
stenosis without spondylolisthesis (as confirmed on imaging) were enrolled in either 
a randomized cohort or an observational cohort at 13 U.S. spine clinics. Treatment 
was decompressive surgery or usual nonsurgical care. The primary outcomes were 
measures of bodily pain and physical function on the Medical Outcomes Study 36-item 
Short-Form General Health Survey (SF-36) and the modified Oswestry Disability 
Index at 6 weeks, 3 months, 6 months, and 1 and 2 years.
Results
A total of 289 patients were enrolled in the randomized cohort, and 365 patients 
were enrolled in the observational cohort. At 2 years, 67% of patients who were 
randomly assigned to surgery had undergone surgery, whereas 43% of those who 
were randomly assigned to receive nonsurgical care had also undergone surgery. 
Despite the high level of nonadherence, the intention-to-treat analysis of the ran-
domized cohort showed a significant treatment effect favoring surgery on the SF-36 
scale for bodily pain, with a mean difference in change from baseline of 7.8 (95% 
confidence interval, 1.5 to 14.1); however, there was no significant difference in 
scores on physical function or on the Oswestry Disability Index. The as-treated 
analysis, which combined both cohorts and was adjusted for potential confounders, 
showed a significant advantage for surgery by 3 months for all primary outcomes; 
these changes remained significant at 2 years.
Conclusions
In the combined as-treated analysis, patients who underwent surgery showed sig-
nificantly more improvement in all primary outcomes than did patients who were 
treated nonsurgically. (ClinicalTrials.gov number, NCT00000411.)
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Spinal stenosis is a narrowing of the spinal canal with encroachment on the neu-ral structures by surrounding bone and soft 
tissue. Patients typically present with radicular leg 
pain or with neurogenic claudication (pain in the 
buttocks or legs on walking or standing that re-
solves with sitting down or lumbar flexion). Spi-
nal stenosis is the most common reason for lum-
bar spine surgery in adults over the age of 65 
years.1,2 Indications for surgery appear to vary 
widely, and rates of procedures vary by at least a 
factor of 5 across geographic areas.3,4 Radio-
graphic evidence of stenosis is frequently asymp-
tomatic; thus, careful clinical correlation between 
symptoms and imaging is critical.5,6
A 2005 Cochrane review found that the pau-
city and heterogeneity of evidence limited conclu-
sions regarding surgical efficacy for spinal steno-
sis. The trials comparing surgical with nonsurgical 
treatment were generally small and involved pa-
tients both with and without degenerative spon-
dylolisthesis.7-12 We know of no randomized 
trials of isolated spinal stenosis without degen-
erative spondylolisthesis.
In the Spine Patient Outcomes Research Trial 
(SPORT), we report on the 2-year outcomes of 
patients with spinal stenosis without degenera-
tive spondylolisthesis to analyze the relative ef-
ficacy of surgical versus nonsurgical treatment.
Me thods
Study Design
SPORT was an investigator-initiated study con-
ducted in 11 states at 13 U.S. medical centers 
with multidisciplinary spine practices. The study 
included both a randomized cohort and a con-
current observational cohort of patients who de-
clined to undergo randomization.13-16 This de-
sign allowed for improved generalizability of the 
findings.17 The ethics committee at each partici-
pating institution approved a standardized pro-
tocol. An independent data and safety monitoring 
board evaluated interim safety and efficacy out-
comes at 6-month intervals.13-16,18 Stopping rules 
were provided on the basis of the alpha spending 
function of DeMets and Lan.19
Patient Population
All patients had a history of neurogenic claudica-
tion or radicular leg symptoms for at least 12 
weeks and confirmatory cross-sectional imaging 
showing lumbar spinal stenosis at one or more 
levels; all patients were judged to be surgical can-
didates. Patients with degenerative spondylolis-
thesis were studied separately.16 Patients with 
lumbar instability (which was defined as transla-
tion of more than 4 mm or 10 degrees of angular 
motion between flexion and extension on upright 
lateral radiographs) were excluded. The type of 
nonsurgical care before enrollment was not pre-
specified but included physical therapy (68% of 
patients), epidural injections (56%), chiropractic 
(28%), the use of antiinflammatory drugs (55%), 
and the use of opioid analgesics (27%).
Research nurses at each site verified eligibil-
ity. Patients were offered enrollment in either co-
hort. To aid in obtaining written informed con-
sent, patients viewed evidence-based videotapes 
with standardized information regarding alterna-
tive treatments.20,21 Patients in the randomized 
cohort received treatment assignments with the 
use of randomly permuted blocks with variable 
block sizes stratified according to center. Patients 
in the observational cohort chose their treatment 
at enrollment with their physician. Enrollment be-
gan in March 2000 and ended in March 2005.
Study Interventions
The protocol surgery was standard posterior de-
compressive laminectomy.13 The nonsurgical pro-
tocol was “usual care,” which was recommended 
to include at least active physical therapy, educa-
tion or counseling with home exercise instruction, 
and the administration of nonsteroidal antiinflam-
matory drugs, if tolerated.13,18
Study Measures
Primary outcomes were measures of bodily pain 
and physical function on the Medical Outcomes 
Study 36-item Short-Form General Health Survey 
(SF-36)22-25 and on the modified Oswestry Dis-
ability Index (American Academy of Orthopaedic 
Surgeons–MODEMS [Musculoskeletal Outcomes 
Data Evaluation and Management Systems] ver-
sion),26 measured at 6 weeks, 3 months, 6 months, 
and 1 and 2 years. (SF-36 scores range from 0 to 
100, with higher scores indicating less severe 
symptoms. The Oswestry Disability Index ranges 
from 0 to 100, with lower scores indicating less 
severe symptoms.)
If surgery was delayed beyond 6 weeks, addi-
tional follow-up data were obtained at 6 weeks 
and at 3 months after surgery. Secondary out-
The New England Journal of Medicine 
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comes included patient-reported improvement, 
satisfaction with current symptoms and care,27 
and the bothersomeness of both stenosis7,28 and 
low back pain.7 The effect of treatment was de-
fined as the difference in the mean change from 
baseline between the surgical group and the non-
surgical group.
Statistical Analysis
For the randomized cohort, we determined that 
a sample size of 185 per group was needed to 
detect a 10-point difference in bodily pain and 
physical function on the SF-36 or a similar effect 
on the Oswestry Disability Index13 on the basis 
of a t-test, with a two-sided significance level of 
0.05 and a power of 85%. Standard deviations for 
changes from baseline were derived from pilot 
data on repeated visits. The sample-size calcula-
tion allowed for 20% missing data but did not 
account for any specific levels of nonadherence.
Initial analyses compared the baseline charac-
teristics of patients in the randomized cohort 
with those in the observational cohort and be-
tween study groups in the combined cohorts. The 
extent of missing data and the percentage of pa-
tients undergoing surgery were calculated accord-
ing to study group for each scheduled follow-up. 
Baseline predictors of the time until surgical 
treatment (including treatment crossovers) in both 
cohorts were determined through a stepwise pro-
portional-hazards regression model with an inclu-
sion criterion of P<0.1 to enter and P>0.05 to exit. 
Predictors of missing follow-up visits at 1 year 
were determined through stepwise logistic re-
gression.
Primary analyses compared surgical and non-
surgical treatments with the use of changes from 
baseline at each follow-up visit, with a mixed-
effects model of longitudinal regression that in-
cluded a random individual effect to account for 
correlation between repeated measurements. The 
randomized cohort was initially analyzed on an 
intention-to-treat basis. Because of crossover, sub-
sequent analyses were based on treatments actu-
ally received. In the as-treated analyses, the treat-
ment indicator was a time-varying covariate, 
allowing for variable times of surgery. For the 
intention-to-treat analyses, all times are from en-
rollment. For the as-treated analysis, the times 
are from the beginning of treatment (i.e., the 
time of surgery for the surgical group and the 
time of enrollment for the nonsurgical group). 
Therefore, all changes from baseline before sur-
gery were included in the estimates of the non-
surgical treatment effect. After surgery, changes 
were assigned to the surgical group, with follow-
up measured from the date of surgery. Repeated 
measures of outcomes were used as the depen-
dent variables, and treatment received was includ-
ed as a time-varying covariate. Adjustments were 
made for the time of surgery with respect to the 
original enrollment date so as to approximate the 
designated follow-up times.
The randomized and observational cohorts 
were each analyzed to produce separate as-treat-
ed estimates of treatment effect. These results 
were compared with the use of a Wald test to 
simultaneously test all follow-up visit times for 
differences in estimated treatment effects be-
tween the two cohorts.29 Subsequent analyses 
combined the two cohorts.
To adjust for potential confounding, baseline 
variables that were associated with missing data 
or treatment received were included as adjusting 
covariates in longitudinal regression models.29 
Computations were performed with the use of 
the PROC MIXED procedure for continuous data 
and the PROC GENMOD procedure for binary 
and non-normal secondary outcomes in SAS 
software, version 9.1 (SAS Institute). Statistical 
significance was defined as P<0.05 on the basis 
of a two-sided hypothesis test with no adjust-
ments made for multiple comparisons. Data for 
these analyses were collected through March 
2, 2007.
R esult s
Patients
A total of 654 patients were enrolled out of 1091 
who were eligible for enrollment: 289 in the ran-
domized cohort and 365 in the observational co-
hort (Fig. 1). In the randomized cohort, 138 pa-
tients were assigned to the surgical group, and 
151 were assigned to the nonsurgical group. In 
the surgery group, 63% had undergone surgery 
at 1 year and 67% at 2 years. In the nonsurgical 
group, 42% had undergone surgery at 1 year and 
Figure 1 (facing page). Enrollment, Randomization,  
and Follow-up.
The numbers of patients who withdrew from the study, 
died, or underwent surgery are cumulative during the 
2­year follow­up period.
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39p6
1091 Were eligible
437 Declined to participate
1696 Patients were screened
605 Were ineligible
277 Were not surgical candidates
90 Had fracture, infection, or deformity
78 Had inadequate nonsugical treatment
41 Had cancer
119 Had other reasons
289 Were enrolled in the
randomized cohort
365 Were enrolled in the
observational cohort
138 Were assigned to surgery
151 Were assigned to
nonsurgical treatment
219 Chose surgery
146 Chose nonsurgical
treatment
116 Were available at 6 wk
20 Missed the follow-up visit
2 Withdrew
25 (18%) Had undergone surgery
130 Were available at 6 wk
21 Missed the follow-up visit
12 (8%) Had undergone surgery
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185 Were available at 6 wk
31 Missed the follow-up visit
2 Withdrew
1 Died
173 (79%) Had undergone surgery
134 Were available at 6 wk
12 Missed the follow-up visit
0 Had undergone surgery
116 Were available at 3 mo
19 Missed the follow-up visit
3 Withdrew
58 (42%) Had undergone surgery
135 Were available at 3 mo
15 Missed the follow-up visit
1 Withdrew
34 (23%) Had undergone surgery
185 Were available at 3 mo
31 Missed the follow-up visit
2 Withdrew
1 Died
197 (90%) Had undergone surgery
130 Were available at 3 mo
14 Missed the follow-up visit
2 Withdrew
5 (3%) Had undergone surgery
120 Were available at 6 mo
13 Missed the follow-up visit
4 Withdrew
1 Died
74 (54%) Had undergone surgery
135 Were available at 6 mo
10 Missed the follow-up visit
6 Withdrew
54 (36%) Had undergone surgery
195 Were available at 6 mo
19 Missed the follow-up visit
4 Withdrew
1 Died
204 (93%) Had undergone surgery
133 Were available at 6 mo
9 Missed the follow-up visit
4 Withdrew
14 (10%) Had undergone surgery
120 Were available at 1 yr
9 Missed the follow-up visit
8 Withdrew
1 Died
87 (63%) Had undergone surgery
126 Were available at 1 yr
14 Missed the follow-up visit
9 Withdrew
2 Died
63 (42%) Had undergone surgery
198 Were available at 1 yr
15 Missed the follow-up visit
5 Withdrew
1 Died
208 (95%) Had undergone surgery
139 Were available at 1 yr
2 Missed the follow-up visit
5 Withdrew
25 (17%) Had undergone surgery
108 Were available at 2 yr
14 Missed the follow-up visit
11 Withdrew
3 Died
2 Had pending visit
92 (67%) Had undergone surgery
113 Were available at 2 yr
14 Missed the follow-up visit
19 Withdrew
4 Died
1 Had pending visit
65 (43%) Had undergone surgery
188 Were available at 2 yr
15 Missed the follow-up visit
14 Withdrew
2 Died
211 (96%) Had undergone surgery
132 Were available at 2 yr
5 Missed the follow-up visit
8 Withdrew
1 Died
32 (22%) Had undergone surgery
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43% at 2 years. In the observational cohort, 219 
patients initially chose surgery and 146 patients 
initially chose nonsurgical care. Of those who 
initially chose surgery, 95% had undergone sur-
gery at 1 year and 96% at 2 years. Of those who 
initially chose nonsurgical treatment, 17% had 
undergone surgery at 1 year and 22% at 2 years. 
In the two cohorts combined, 400 patients re-
ceived surgery at some point during the first 
2 years, and 254 received nonsurgical treatment.
The proportion of enrollees who supplied data 
at each follow-up interval ranged from 83 to 89%, 
with losses due to dropouts, missed visits, or 
deaths. A total of 634 patients, each with at least 
one follow-up through 2 years, were included in 
the analysis, including 278 patients (96%) in the 
randomized cohort and 356 patients (98%) in the 
observational cohort.
Characteristics of the Patients
Characteristics of the patients at baseline in the 
two cohorts are compared in Table 1. Overall, 
the cohorts were similar. However, patients in 
the observational cohort had more signs of nerve-
root tension and less lateral recess stenosis and 
expressed stronger treatment preferences than did 
patients in the randomized cohort.
Summary statistics for the combined cohorts 
are also shown in Table 1, according to treat-
ment received. The study population had a mean 
age of 65 years; a majority were white men who 
had attended college. Of these patients, 80% had 
classic neurogenic claudication, and 79% had as-
sociated dermatomal pain radiation; 91% had 
stenosis at L4 or L5, and 61% had more than one 
level of stenosis. For most patients, the overall 
stenosis was graded as severe.
At baseline, the group undergoing surgery was 
younger and more likely to be working than was 
the group that did not undergo surgery. Patients 
in the surgical group had more pain, a lower 
level of function, more psychological distress, 
and more self-reported disability than did patients 
in the nonsurgical group. In addition, patients in 
the surgical group had symptoms that were more 
bothersome and radiographic evidence of more 
severe stenosis. The surgical group was more of-
ten dissatisfied with their symptoms and more 
often rated the symptoms as worsening than did 
patients in the nonsurgical group.
The final models, combining both cohorts, 
were adjusted for age, sex, coexisting disorders of 
the stomach or joints, the presence or absence 
of pain on straight-leg raising or femoral-nerve 
tension signs, smoking status, patient-assessed 
health trend, income, other compensation, body-
mass index, baseline score for the outcome vari-
able, and center.
Nonsurgical Treatments
At 2 years, nonsurgical treatments were similar 
in the two cohorts. However, more patients in the 
randomized group than in the observational group 
reported visits to a surgeon (45% vs. 32%, P = 0.02) 
and receiving injections (52% vs. 39%, P = 0.02), 
whereas more patients in the observational group 
reported the use of “other” medications, such as 
gabapentin (60% vs. 73%, P = 0.01).
Surgical Treatments and Complications
Overall, surgical treatments and complications 
were similar in the two cohorts (Table 2). Among 
patients in the surgical group, 89% underwent 
decompression only. Instrumented fusion was 
performed in only 6% of patients. The median 
surgical time was 120 minutes, with a mean 
blood loss of 314 ml; 10% of patients required 
transfusions intraoperatively and 5% postopera-
tively. The most common surgical complication 
was dural tear, in 9% of patients. At 2 years, re-
operation had occurred in 8% of patients; fewer 
than half of these operations were for recurrent 
stenosis.
At 2 years, there were seven deaths in the 
nonsurgical group and six in the surgical group, 
one of which occurred within 3 months after 
surgery. The deaths were reviewed and 12 were 
judged not to be treatment-related. The one 
death of unknown cause occurred 501 days after 
surgery.
Crossover
Nonadherence to treatment assignment affected 
both study cohorts: some patients in the surgical 
group chose to delay or decline surgery, and some 
in the nonsurgical group crossed over to undergo 
surgery (Fig. 1). The characteristics of crossover 
patients that differed significantly from patients 
who did not cross over are shown in Table 3. 
Patients in the nonsurgical group who crossed 
The New England Journal of Medicine 
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Table 1. Demographic Characteristics, Coexisting Illnesses, and Measures of Health Status of the Patients.*
Variable SPORT Study Cohort Combined Randomized and Observational Cohorts
 
Randomized 
Group 
(N = 278)
Observational 
Group 
(N = 356) P Value
Surgical  
Group 
(N = 394)
Nonsurgical  
Group 
(N = 240) P Value
Age — yr 65.5±10.5 63.9±12.5 0.10 63.6±12.2 66.3±10.5 0.004
Female sex — no. (%) 106 (38) 143 (40) 0.66 152 (39) 97 (40) 0.71
Race or ethnic background — no. (%)†
Non­Hispanic 259 (93) 346 (97) 0.03 378 (96) 227 (95) 0.55
White 238 (86) 295 (83) 0.41 332 (84) 201 (84) 0.95
Attended college — no. (%) 176 (63) 225 (63) 0.96 245 (62) 156 (65) 0.53
Married — no. (%) 197 (71) 249 (70) 0.87 288 (73) 158 (66) 0.06
Employment status — no. (%)  0.12  0.05
Full­time or part­time  88 (32) 128 (36)  144 (37) 72 (30)  
Disabled 24 (9)  36 (10)   40 (10) 20 (8)  
Retired 144 (52) 152 (43)  167 (42) 129 (54)  
Other 22 (8)  40 (11)   43 (11) 19 (8)  
Disability compensation — no. (%)‡ 21 (8) 27 (8) 0.89 30 (8) 18 (8) 0.92
Body­mass index§ 29.8±5.6 29.3±5.6 0.31 29.3±5.3 29.9±6.1 0.25
Current smoker — no. (%) 34 (12) 28 (8) 0.09 36 (9) 26 (11) 0.58
Coexisting condition — no. (%)       
Hypertension 134 (48) 154 (43) 0.25 168 (43) 120 (50) 0.09
Diabetes 50 (18) 46 (13) 0.10 53 (13) 43 (18) 0.16
Osteoporosis 22 (8) 38 (11) 0.30 30 (8) 30 (12) 0.06
Heart disorder 80 (29) 85 (24) 0.19 95 (24) 70 (29) 0.19
Stomach disorder 60 (22) 79 (22) 0.93 82 (21) 57 (24) 0.44
Bowel or intestinal disorder 36 (13) 50 (14) 0.78 49 (12) 37 (15) 0.35
Depression 36 (13) 34 (10) 0.22 41 (10) 29 (12) 0.60
Joint disorder 158 (57) 188 (53) 0.35 210 (53) 136 (57) 0.46
Other disorder¶ 95 (34) 125 (35) 0.87 136 (35) 84 (35) 0.97
Symptom duration >6 mo — no. (%) 158 (57) 210 (59) 0.64 236 (60) 132 (55) 0.26
SF­36 score‖
Bodily pain 31.9±17.5 31.4±17.4 0.73 28.6±16.2 36.6±18.4 <0.001
Physical function 35.4±22.6 34.3±23.8 0.55 31.7±21.9 39.9±24.5 <0.001
Mental component summary 49.8±12.4 49.1±11.6 0.47 48.5±12.0 50.9±11.7 0.02
Oswestry Disability Index** 42.7±17.9 42.1±19.0 0.70 46.0±17.9 36.4±17.9 <0.001
Stenosis Frequency Index†† 13.5±5.7 14.2±5.8 0.13 15.2±5.6 11.8±5.6 <0.001
Stenosis Bothersomeness Index‡‡ 13.9±5.7 14.7±5.8 0.08 15.6±5.4 12.3±5.7 <0.001
Low Back Pain Bothersomeness Scale§§ 4.0±1.9 4.2±1.8 0.19 4.3±1.8 3.8±1.8 0.002
Leg Pain Bothersomeness Scale¶¶ 4.3±1.7 4.4±1.7 0.44 4.6±1.6 3.9±1.8 <0.001
Patient very dissatisfied with symptoms 
— no. (%)
183 (66) 250 (70) 0.27 309 (78) 124 (52) <0.001
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Table 1. (Continued.)
Variable SPORT Study Cohort Combined Randomized and Observational Cohorts
 
Randomized 
Group 
(N = 278)
Observational 
Group 
(N = 356) P Value
Surgical  
Group 
(N = 394)
Nonsurgical 
 Group 
(N = 240) P Value
Patient’s self­assessed health trend  
— no. (%)
0.48  <0.001
Problem getting better 18 (6) 28 (8)  14 (4)  32 (13)  
Problem staying about the same 95 (34) 108 (30)  108 (27)  95 (40)  
Problem getting worse 160 (58) 218 (61)  265 (67) 113 (47)  
Treatment preference — no. (%)   <0.001   <0.001
Nonsurgical 
Definitely 37 (13) 86 (24)   36 (9) 87 (36)  
Probably 61 (22)  45 (13)   36 (9) 70 (29)  
Not sure 95 (34)  26 (7)   61 (15) 60 (25)  
Surgical
Definitely 33 (12) 163 (46)  188 (48)  8 (3)  
Probably 51 (18)  36 (10)   73 (19) 14 (6)  
Signs and symptoms — no. (%)
Neurogenic claudication 219 (79) 289 (81) 0.51 317 (80) 191 (80) 0.87
Pain on straight­leg raising or  
femoral­nerve tension sign
41 (15) 91 (26) 0.001 85 (22) 47 (20) 0.62
Dermatomal pain radiation 215 (77) 284 (80) 0.52 310 (79) 189 (79) 0.94
Any neurologic deficit 146 (53) 203 (57) 0.29 210 (53) 139 (58) 0.29
Asymmetric depressed reflexes 76 (27) 92 (26) 0.74 102 (26) 66 (28) 0.72
Asymmetric decrease in sensory 
reflexes
68 (24) 114 (32) 0.05 116 (29) 66 (28) 0.66
Asymmetric motor weakness 71 (26) 106 (30) 0.28 104 (26) 73 (30) 0.32
Stenosis level — no. (%)     
L2–L3 77 (28) 102 (29) 0.86 121 (31) 58 (24) 0.09
L3–L4 183 (66) 237 (67) 0.91 266 (68) 154 (64) 0.44
L4–L5 255 (92) 324 (91) 0.86 362 (92) 217 (90) 0.63
L5–S1 72 (26) 101 (28) 0.55 100 (25) 73 (30) 0.20
Moderate or severe stenotic levels — 
no. (%)
 0.45  0.19
0  4 (1)  11 (3)   6 (2)  9 (4)  
1 106 (38) 128 (36)  140 (36) 94 (39)  
2 109 (39) 132 (37)  153 (39) 88 (37)  
≥3  59 (21)  85 (24)   95 (24) 49 (20)  
Location of stenosis — no. (%)       
Central 241 (87) 302 (85) 0.58 338 (86) 205 (85) 0.99
Lateral recess 236 (85) 267 (75) 0.003 321 (81) 182 (76) 0.11
Neuroforamen 88 (32) 119 (33) 0.70 119 (30) 88 (37) 0.11
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over to undergo surgery had more self-rated dis-
ability, more psychological distress, worse symp-
toms, and a stronger treatment preference for 
surgery at baseline than did patients who did not 
opt for surgery. Patients in the surgical group 
who crossed over to receive nonsurgical care were 
more often not white, had less bothersome symp-
toms, less often rated their symptoms as worsen-
ing at enrollment, and had a stronger treatment 
preference for nonsurgical care at baseline.
Main Treatment Effects
In the intention-to-treat analysis, a significant 
treatment effect favoring surgery was seen at 
2 years, with a mean difference in change from 
baseline of 7.8 (95% confidence interval [CI], 1.5 
to 14.1) on the SF-36 scale for bodily pain; at 
earlier times, there was a smaller nonsignificant 
effect in favor of surgery. However, at 2 years, 
there were no significant differences between 
the surgical group and the nonsurgical group on 
the SF-36 scale for physical function (0.1; 95% 
CI, −6.4 to 6.5) or on the Oswestry Disability In-
dex (−3.5; 95% CI, −8.7 to 1.7) (Table 4).
In the as-treated analysis, the mean differences 
in change from baseline in the randomized and 
observational cohorts were similar at 2 years: 
bodily pain, 11.7 (95% CI, 6.2 to 17.2) in the 
randomized group versus 15.3 (95% CI, 10.4 to 
20.2) in the observational group; physical func-
tion, 8.1 (95% CI, 2.8 to 13.5) in the randomized 
group versus 13.6 (95% CI, 8.7 to 18.4) in the 
observational group; and Oswestry Disability In-
dex, −8.7 (95% CI, −13.3 to −4.0) in the random-
ized group versus −13.1 (95% CI, −16.9 to −9.2) 
in the observational group (Fig. 2).
The global hypothesis test comparing the as-
treated effects in the randomized group and the 
observational group over all time periods showed 
no difference between the two cohorts (P = 0.93 
for bodily pain, P = 0.67 for physical function, and 
P = 0.60 for the Oswestry Disability Index).
Results from the intention-to-treat analysis 
and the as-treated analysis of the two cohorts 
are compared in Figure 2. The effects shown in 
the as-treated analysis significantly favored sur-
gery in both cohorts. In the combined analysis, 
treatment effects were significant in favor of sur-
Table 1. (Continued.)
Variable SPORT Study Cohort Combined Randomized and Observational Cohorts
 
Randomized 
Group 
(N = 278)
Observational 
Group 
(N = 356) P Value
Surgical  
Group 
(N = 394)
Nonsurgical  
Group 
(N = 240) P Value
Severity of stenosis — no. (%)  0.24  0.006
Mild  4 (1)  11 (3)   6 (2)  9 (4)  
Moderate 131 (47) 151 (42)  161 (41) 121 (50)  
Severe 143 (51) 194 (54)  227 (58) 110 (46)  
Spinal instability 0 0  0 0  
* Plus–minus values are means ±SD. Patients in the combined two cohorts were classified according to whether they received surgical treat­
ment or nonsurgical treatment during the first 2 years of enrollment. Numbers of patients include only those who completed at least one 
follow­up survey within 2 years after enrollment.
† Race or ethnic group was self­reported. Whites and blacks could be either Hispanic or non­Hispanic.
‡ This category includes patients who were receiving or had applications pending for workers’ compensation, Social Security benefits, or 
other compensation.
§ The body­mass index is the weight in kilograms divided by the square of the height in meters.
¶ Other disorders included problems related to stroke, cancer, lung disorders, fibromyalgia, chronic fatigue syndrome, post­traumatic stress 
disorder, alcohol or drug dependency, migraine, anxiety, or disorders of the liver, kidney, blood vessels, or nervous system.
‖ Scores on the Medical Outcomes Study 36­item Short­Form General Health Survey (SF­36) range from 0 to 100, with higher scores indi­
cating less severe symptoms.
** The Oswestry Disability Index ranges from 0 to 100, with lower scores indicating less severe symptoms.
†† The Stenosis Frequency Index ranges from 0 to 24, with lower scores indicating less severe symptoms.
‡‡ The Stenosis Bothersomeness Index ranges from 0 to 24, with lower scores indicating less severe symptoms.
§§ The Low Back Pain Bothersomeness Scale ranges from 0 to 6, with lower scores indicating less severe symptoms.
¶¶ The Leg Pain Bothersomeness Scale ranges from 0 to 6, with lower scores indicating less severe symptoms.
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Table 2. Surgical Treatments, Complications, and Events.*
Variable
Randomized Cohort 
(N = 155)
Observational Cohort 
(N = 239) P Value
Procedure — no./total no. (%)   0.49
Decompression only 137/154 (89) 209/235 (89)
Noninstrumented fusion  6/154 (4)  14/235 (6)  
Instrumented fusion  11/154 (7)  12/235 (5)
Multilevel fusion — no./total no. (%) 5/155 (3) 11/239 (5) 0.68
Decompression level — no./total no. (%)
L2–L3 53/152 (35) 90/235 (38) 0.57
L3–L4 115/152 (76) 157/235 (67) 0.081
L4–L5 140/152 (92) 218/235 (93) 0.97
L5–S1 60/152 (39) 89/235 (38) 0.83
Levels decompressed — no./total no. (%)   0.92
None  3/155 (2)  4/239 (2)
1 33/155 (21)  54/239 (23)  
2 47/155 (30)  78/239 (33)
≥3 72/155 (46) 103/239 (43)  
Operation time — min 128.4±64.7 127.8±66.2 0.93
Blood loss — ml 338.5±527.1 295.6±312.6 0.31
Blood replacement — no./total no. (%)
Intraoperative transfusion 14/152 (9) 23/238 (10) 0.98
Postoperative transfusion 6/153 (4) 13/238 (5) 0.65
No. of days in hospital 3.5±2.6 3.0±2.2 0.13
Postoperative mortality — no./total no. (%)†
Within 6 wk 0/155 1/239 (<1) 0.83
Within 3 mo 0/155 1/239 (<1) 0.83
Intraoperative complications — no./total no. (%)‡
Dural tear or spinal fluid leak 13/155 (8) 23/238 (10) 0.80
Other 1/155 (1) 2/238 (1) 0.71
None 141/155 (91) 213/238 (89) 0.76
Postoperative complications or events — no./total no. (%)§
Wound hematoma 3/153 (2) 1/238 (<1) 0.34
Wound infection 3/153 (2) 5/238 (2) 0.79
Other 8/153 (5) 13/238 (5) 0.90
None 135/153 (88) 208/238 (87) 0.93
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gery for all primary and secondary outcome 
measures at each time point during the 2 years 
(Table 4).
Discussion
In patients with imaging-confirmed spinal steno-
sis without spondylolisthesis and leg symptoms 
persisting for at least 12 weeks, surgery was su-
perior to nonsurgical treatment in relieving symp-
toms and improving function. In the as-treated 
analysis, the treatment effect for surgery was 
seen as early as 6 weeks, appeared to reach a 
maximum at 6 months, and persisted for 2 years; 
it is notable that the condition of patients in the 
nonsurgical group improved only moderately dur-
ing the 2-year period. The intention-to-treat re-
sults must be viewed in the context of the sub-
stantial rates of nonadherence to assigned treat-
ment. The pattern of nonadherence was striking 
because both the surgical and the nonsurgical 
groups were affected, unlike the results of many 
studies involving surgical procedures.30 The mix-
ing of treatments owing to crossover can be ex-
pected to create a bias toward the null.31 The 
large effects seen in the as-treated analysis and 
the characteristics of the crossover patients sug-
gest that the intention-to-treat analysis underes-
timated the true effect of surgery.
This study provides an opportunity to compare 
Table 2. (Continued.)
Variable
Randomized Cohort 
(N = 155)
Observational Cohort 
(N = 239) P Value
Additional surgery — no./total no. (%)¶
Any surgery
At 1 yr 6/157 (4) 15/243 (6) 0.29
At 2 yr 10/157 (6) 21/243 (9) 0.39
Recurrent stenosis or progressive spondylolisthesis
At 1 yr 3/155 (2) 2/241 (1)
At 2 yr 6/155 (4) 5/241 (2)
Pseudarthrosis or fusion exploration
At 1 yr 0/155 0/239  
At 2 yr 0/155 0/239
Complication or other problem
At 1 yr 3/155 (2) 10/241 (4)
At 2 yr 4/155 (3) 11/241 (5)
New condition
At 1 yr 0/155 2/241 (1)  
At 2 yr 1/155 (1) 5/241 (2)
* Plus–minus values are means ±SD. A total of 157 patients in the randomized cohort and 243 patients in the observational 
cohort underwent surgery. Data are missing for patients in some categories, as indicated by varying denominators.
† One patient had a myocardial infarction.
‡ None of the following were reported: aspiration, nerve­root injury, operation at wrong level, and vascular injury.
§ This category includes all reported complications up to 8 weeks after surgery. None of the following were reported: 
bone­graft complication, cerebrospinal fluid leak, paralysis, cauda equina injury, wound dehiscence, pseudarthrosis,  
and nerve­root injury.
¶ Rates of repeated surgery at 1 and 2 years are Kaplan–Meier estimates. P values were calculated with the use of the log­
rank test.
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results involving patients who were willing to par-
ticipate in a randomized study (randomized co-
hort) and those who were unwilling to partici-
pate in such a study (observational cohort).13-16 
These two cohorts were remarkably similar at 
baseline. Other than treatment preference, the 
only significant differences were small ones in 
signs of nerve-root tension and the location of 
stenosis. The two cohorts also had similar out-
comes, without significant differences in the as-
treated analyses. Given these similarities, the 
combined analyses are well justified. Although 
these analyses are not based on randomized 
treatment assignments, the results are strength-
ened by the use of specific inclusion and exclu-
sion criteria, the sample size, and adjustment for 
potentially confounding baseline differences.32
The characteristics of the patients were simi-
lar to those in previous studies, even though the 
latter involved mixed-cohort patients (i.e., those 
with or without spondylolisthesis). In our study, 
the functional status of the patients at baseline 
was similar to that of patients in the Maine 
Lumbar Spine Study7,8 (SF-36 score, 34.8 and 35.0, 
respectively) but worse than that in the study by 
Malmivaara et al.10,11 (Oswestry Disability Index, 
42.4 and 35.0, respectively).
In the as-treated analysis, the functional im-
provement in the surgical group at 1 year was 
very similar to that in the Maine Lumbar Spine 
Table 3. Significant Predictors of Treatment Received within 2 Years among Patients in the Randomized Cohort.*
Predictor Assigned to Surgical Group Assigned to Nonsurgical Group
Surgery 
(N = 89)
No Surgery 
(N = 43) P Value
Surgery 
(N = 64)
No Surgery 
(N = 82) P Value
White race — no. (%) 80 (90) 29 (67) 0.003 58 (91) 71 (87) 0.62
Mental Component Summary score† 49.9±12.2 50.4±14.0 0.84 47.0±12.6 51.6±11.2 0.02
Oswestry Disability Index‡ 44.6±18.2 38.9±18.8 0.10 46.7±18 39.4±16.2 0.01
Stenosis Frequency Index§ 14.8±5.3 11.6±6.2 0.002 14.7±5.5 12.1±5.5 0.005
Stenosis Bothersomeness Index¶ 15.0±4.9 12.0±6.0 0.002 15.3±5.5 12.6±6.1 0.005
Leg Pain Bothersomeness Scale‖ 4.5±1.6 4.0±1.9 0.09 4.6±1.5 3.9±1.8 0.01
Very dissatisfied with symptoms — no. (%) 65 (73) 25 (58) 0.13 49 (77) 44 (54) 0.007
Problem getting better or worse — no. (%)   0.009   0.31
Getting better 2 (2) 6 (14)   2 (3)  8 (10)  
Staying about the same 27 (30) 18 (42)  22 (34) 28 (34)  
Getting worse 57 (64) 19 (44)  38 (59) 46 (56)  
Treatment preference — no. (%)   0.01  <0.001
Nonsurgical
Definitely 9 (10) 8 (19)   7 (11) 13 (16)  
Probably 15 (17) 15 (35)   9 (14) 22 (27)  
Not sure 31 (35) 13 (30)  15 (23) 36 (44)  
Surgical
Definitely 11 (12) 0  17 (27) 5 (6)  
Probably 23 (26) 7 (16)  16 (25) 5 (6)  
* Plus–minus values are means ±SD. Numbers of patients include only those who completed at least one follow­up survey within 2 years after 
enrollment.
† Scores on the Medical Outcomes Study 36­item Short­Form General Health Survey (SF­36) range from 0 to 100, with higher scores indicat­
ing less severe symptoms.
‡ The Oswestry Disability Index ranges from 0 to 100, with lower scores indicating less severe symptoms.
§ The Stenosis Frequency Index ranges from 0 to 24, with lower scores indicating less severe symptoms.
¶ The Stenosis Bothersomeness Index ranges from 0 to 24, with lower scores indicating less severe symptoms.
‖ The Leg Pain Bothersomeness Scale ranges from 0 to 6, with lower scores indicating less severe symptoms.
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Figure 2. Primary Outcomes in the Randomized and Observational Cohorts during 2 Years of Follow-up.
The graphs show both the intention­to­treat and the as­treated analyses for the randomized cohort (column on left) 
and the as­treated analysis for the observational cohort (column on right). Results for bodily pain and physical func­
tion are scores on the Medical Outcomes Study 36­item Short­Form General Health Survey (SF­36), ranging from 0 
to 100, with higher score indicating less severe symptoms. The Oswestry Disability Index (bottom row) ranges from  
0 to 100, with lower scores indicating less severe symptoms. The horizontal dashed line in each of the four SF­36 
graphs represents normal values adjusted for age and sex. The I ars represent 95% confidence intervals. At 0 months, 
the floating data points represent the observed mean scores for each study group, whereas the data points on plot 
lines represent the overall means used in the adjusted analyses.
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Table 4. Intention-to-Treat Analysis for the Randomized Cohort and Adjusted Analyses, According to Treatment Received, for the Randomized 
 Outcome Baseline At 6 Wk At 3 Mo
 
Overall 
Mean Surgery No Surgery
Treatment Effect  
(95% CI)† Surgery No Surgery
Treatment Effect 
(95% CI)†
  Mean Change Mean Change
Intention-to-treat analysis of randomized cohort
No. of patients 278 116 130  116 135  
Primary outcome      
SF­36‡
Bodily pain 31.9±1.1 11.2±2.4 7.9±2.2 3.3 (−3.2 to 9.8) 13.5±2.5 11.1±2.3 2.4 (−4.2 to 9.1)
Physical function 35.4±1.4 6.0±2.5 10.2±2.3 −4.2 (−10.8 to 2.4) 7.4±2.5 11.6±2.3 −4.2 (−10.9 to 2.6)
Oswestry Disability Index§ 42.7±1.1 −6.5±2.0 −7.9±1.8 1.4 (−3.9 to 6.8) −7.6±2.1 −8.1±1.9 0.5 (−5.0 to 6.0)
Secondary outcome      
Stenosis Bothersomeness 
Index¶
13.9±0.3 NA NA NA −4.5±0.8 −3.8±0.7 −0.7 (−2.8 to 1.5)
Leg Pain Bothersomeness Index‖ 4.3±0.1 NA NA NA −1.5±0.3 −1.2±0.2 −0.3 (−1.0 to 0.4)
Low Back Pain Bothersomeness 
Index**
4.0±0.1 NA NA NA −0.6±0.2 −1.0±0.2 0.4 (−0.2 to 1.0)
Satisfaction of patient (%)
Very or somewhat satisfied 
with symptoms
5.0 22.0 27.9 −5.9 (−18.0 to 6.2) 38.1 33.7 4.3 (−9.6 to 18.2)
Very or somewhat satisfied 
with care
NA 68.7 71.8 −3.1 (−15.9 to 9.7) 71.6 77.0 −5.4 (−18.0 to 7.2)
Self­rated major improve­
ment in condition
NA 19.7 25.8 −6.1 (−18.0 to 5.9) 30.9 35.4 −4.5 (−18.2 to 9.3)
As-treated analysis of randomized and observational cohorts††
No. of patients 803 398 370  378 313  
Primary outcome      
SF­36‡
Bodily pain 31.4±0.6 19.8±1.1 9.8±1.1 10.0 (7.3 to 12.7) 27.9±1.1 11.8±1.2 16.1 (13.1 to 19.1)
Physical function 34.9±0.8 17.8±1.1 8.7±1.1 9.1 (6.5 to 11.8) 24.8±1.2 10.0±1.2 14.8 (11.9 to  17.7)
Oswestry Disability Index§ 43.2±0.6 −17.0±0.9 −6.8±0.9 −10.3 (−12.5 to −8.1) −21.4±0.9 −7.6±1.0 −13.8 (−16.2 to −11.3)
Secondary outcome      
Stenosis Bothersomeness 
Index¶
14.4±0.2 NA NA NA −8.6±0.4 −2.9±0.4 −5.7 (−6.7 to −4.6)
Leg Pain Bothersomeness Scale‖ 4.3±0.1 NA NA NA −2.7±0.1 −0.9±0.1 −1.8 (−2.1 to −1.5)
Low Back Pain Bothersomeness 
Scale**
4.1±0.1 NA NA NA −2.0±0.1 −0.8±0.1 −1.2 (−1.5 to  −0.9)
Satisfaction of patient (%)
Very or somewhat satisfied 
with symptoms
5.7 64.0 18.5 45.5 (39.2 to 51.8) 61.9 22.8 39.1 (32.0 to 46.1)
Very or somewhat satisfied 
with care
NA 90.1 67.5 22.7 (16.8 to 28.5) 90.1 71.3 18.7 (12.6 to 24.9)
Self­rated major improve­
ment in condition
NA 72.0 18.2 53.8 (48.0 to 59.6) 72.0 20.0 52.0 (45.6 to 58.3)
* Plus–minus values are means ±SE. Values in the as­treated analysis have been adjusted for age, sex, the presence or absence of stomach or 
joint disorders, the presence or absence of pain on straight­leg raising or femoral­nerve tension signs, smoking status, patient­assessed 
health trend, income, other compensation, body­mass index, baseline score for the outcome variable, and center. NA denotes not available.
† The treatment effect is the difference in the mean change from baseline between the surgical group and the nonsurgical group.
‡ The SF­36 scores range from 0 to 100, with higher scores indicating less severe symptoms.
§ The Oswestry Disability Index ranges from 0 to 100, with lower scores indicating less severe symptoms.
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and Observational Cohorts Combined.*
At 6 Mo At 1 Yr At 2 Yr
Surgery No Surgery
Treatment Effect 
(95% CI)† Surgery No Surgery
Treatment Effect 
(95% CI)† Surgery No Surgery
Treatment 
Effect (95% CI)†
Mean Change Mean Change Mean Change
120 135  120 126   108 113  
      
21.0±2.2 16.1±2.1 4.9 (−1.2 to 10.9) 23±2.3 17.5±2.2 5.5 (−0.7 to 11.7) 23.4±2.3 15.6±2.2 7.8 (1.5 to 14.1)
17.6±2.3 15.1±2.2 2.5 (−3.7 to 8.6) 18.0±2.3 16.4±2.2 1.6 (−4.8 to 7.9) 17.1±2.4 17.1±2.3 0.1 (−6.4 to 6.5)
−14.6±1.9 −13.7±1.7 −0.9 (−5.9 to 4.1) −14.9±1.9 −12.7±1.8 −2.2 (−7.4 to 2.9) −16.4±1.9 −12.9±1.8 −3.5 (−8.7 to 1.7)
      
NA NA NA −6.1±0.7 −4.9±0.7 −1.2 (−3.2 to 0.8) −6.3±0.7 −5.6±0.7 −0.7 (−2.7 to 1.3)
NA NA NA −2.3±0.2 −1.7±0.2 −0.6 (−1.3 to 0) −2.2±0.2 −1.8±0.2 −0.3 (−1.0 to 0.3)
NA  NA NA −1.3±0.2 −1.3±0.2 0 (−0.5 to 0.6) −1.3±0.2 −1.6±0.2 0.3 (−0.2 to 0.9)
49.9 38.3 11.7 (−0.8 to 24.1) 53.4 40.7 12.8 (−0.3 to 25.8) 53.1 45.0 8.1 (−5.3 to 21.5)
85.0 73.1 11.9 (1.9 to 21.9) 81.4 69.3 12.0 (0.8 to 23.2) 76.2 68.5 7.6 (−4.5 to 19.7)
49.0 46.2 2.8 (−10.0 to 15.5) 55.3 44.2 11.1 (−2.1 to  24.2) 50.7 45.0 5.8 (−7.8 to 19.3)
 256 271  302 230  335 198  
      
29.5±1.3 12.9±1.2 16.6 (13.3 to 19.9) 28.0±1.2 13.5±1.4 14.6 (11.2 to 18) 26.9±1.2 13.3±1.4 13.6 (10.0 to 17.2)
26.9±1.3 10.6±1.3 16.3 (13.1 to 19.6) 26.5±1.2 10.5±1.4 15.9 (12.6 to 19.3) 23.0±1.3 11.8±1.4 11.1 (7.6 to 14.7)
−22.9±1.0 −8.8±1.0 −14.1 (−16.8 to −11.4) −21.4±1.0 −8.9±1.1 −12.5 (−15.3 to −9.8) −20.5±1.0 −9.3±1.2 −11.2 (−14.1 to −8.3)
      
NA NA NA −8.2±0.3 −3.9±0.4 −4.4 (−5.4 to −3.3) −7.8±0.4 −4.4±0.4 −3.4 (−4.5 to −2.3)
NA NA NA −2.6±0.1 −1.4±0.1 −1.2 (−1.5 to −0.9) −2.5±0.1 −1.4±0.1 −1.1 (−1.4 to −0.7)
NA NA NA −2.0±0.1 −1.0±0.1 −1.0 (−1.3 to −0.7) −2.0±0.1 −1.1±0.1 −1.0 (−1.3 to −0.6)
62.8 26.3 36.5 (28.6 to 44.4) 67.6 29.2 38.4 (30.3 to 46.5) 68.2 29.6 38.7 (30.0 to 47.3)
90.8 67.3 23.5 (16.7 to 30.3) 86.1 69.1 17.0 (9.6 to 24.4) 83.1 67.0 16.1 (7.8 to 24.3)
67.0 24.9 42.1 (34.5 to 49.6) 68.8 25.4 43.4 (35.7 to 51.1) 62.9 28.7 34.1 (25.6 to 42.6)
¶ The Stenosis Bothersomeness Index ranges from 0 to 24, with lower scores indicating less severe symptoms.
‖ The Leg Pain Bothersomeness Scale ranges from 0 to 6, with lower scores indicating less severe symptoms.
** The Low Back Pain Bothersomeness Scale ranges from 0 to 6, with lower scores indicating less severe symptoms.
†† The number of patients in the as­treated analyses reflects the number of patients contributing to the estimate in a given period with the 
use of the longitudinal­modeling strategy (explained in the Methods section) and may not correspond to the number shown for each visit 
time in Figure 1.
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Study (26.5 and 27.0, respectively) but greater 
than in the study by Malmivaara et al. (Oswestry 
Disability Index, −21.4 and −11.3, respectively). 
Functional improvement in the nonsurgical group 
was greater in our study than in the previous 
studies, with a change of 10.5 in the SF-36 physical 
function score at 1 year, as compared with 1.0 
in the Maine Lumbar Spine Study, and a change 
of 9.3 in the Oswestry Disability Index at 2 years, 
as compared with 4.5 in the study by Malmi-
vaara et al. The greater improvements in our 
study, compared with those in the study by Mal-
mivaara et al., may be related to differences in 
the selection of patients. In the study by Malmi-
vaara et al., patients with moderate spinal steno-
sis were specifically selected, whereas in our 
study, we attempted to enroll patients with spinal 
stenosis who were surgical candidates.
In the as-treated analysis, we can directly com-
pare the estimates of treatment effect with those 
of the previous studies. The estimated 1-year 
treatment effects for surgery were smaller in our 
study than in the Maine Lumbar Spine Study 
(changes in bodily pain of 14.6 and 30.4, respec-
tively, and in physical function of 15.9 and 25.5, 
respectively). However, in the Maine Lumbar 
Spine Study, treatment effects for baseline dif-
ferences between the study groups were not ad-
justed, which probably explains these discrepan-
cies. At 1 year, the estimated treatment effects 
were similar in our study and the study by Malmi-
vaara et al.: Oswestry Disability Index, −12.5 and 
−11.3, respectively; leg pain, 17% (on a 7-point 
scale) and 15% (on an 11-point scale); and back 
pain, 14% (on a 7-point scale) and 21% (on an 
11-point scale).
It is interesting that among patients who un-
derwent surgery, the magnitude of the mean 
changes in patients with spinal stenosis was 
nearly identical to that in the patients with degen-
erative spondylolisthesis at 2 years: bodily pain, 
26.9 and 29.9, respectively; physical function, 23.0 
and 26.6; Oswestry Disability Index, −20.5 and 
−24.2; and bothersomeness of symptoms, −7.8 
and −8.9.16 The treatment effects in these stud-
ies of spinal stenosis were larger than those in 
the observational study of patients with inter-
vertebral disk herniation because of strong im-
provements in the nonsurgical group of patients 
with intervertebral disk herniation that were not 
seen in either stenosis group.14-16
There was little evidence of harm from either 
treatment. Often patients fear they will get worse 
without surgery, but this was not the case for the 
majority of patients in the nonsurgical group, 
who, on average, showed small improvements in 
all outcomes. The 1-year rate of reoperation for 
recurrent stenosis was 1.3%, a rate similar to 
those reported by Malmivaara et al. (2%) and by 
the Maine Lumbar Spine Study (1.2%). At 2 years, 
mortality was nearly the same in the two study 
groups and was lower than actuarial projections. 
The postoperative death rate of 0.3% and the 
overall postoperative complication rate of 12% 
were slightly better than the reported Medicare 
rates in patients with spinal stenosis who did not 
undergo spinal fusion (death rate, 0.8%; rate of 
complications, 14%).1 However, higher rates of 
complications have been reported with increasing 
age and coexisting medical conditions.33
The primary limitation of our study was the 
marked degree of nonadherence to randomized 
treatment. This factor reduced the power of the 
intention-to-treat analysis to show treatment ef-
fects, though there was still a significant treat-
ment effect for the measure of bodily pain at 
2 years. The as-treated analyses do not share the 
strong protection from confounding that exists 
for the intention-to-treat analyses. However, these 
analyses were carefully adjusted for important 
baseline covariates and yielded results similar to 
those of previous studies. The characteristics of 
the crossover patients were as one might expect: 
those with severe symptoms and a preference for 
surgery crossed over into the surgical group, and 
vice versa.
Another limitation was the heterogeneity of 
the nonsurgical treatments. Given the limited 
evidence regarding efficacy of most nonsurgical 
treatments for spinal stenosis and individual vari-
ability in response, the creation of a limited, 
fixed protocol for nonsurgical treatment was 
neither clinically feasible nor generalizable. The 
flexible treatment protocols allowed for individ-
ualization of nonsurgical treatment plans, reflect 
current practice among multidisciplinary spine 
practices, and were consistent with published 
guidelines.34,35 However, we did not assess the 
effect of surgery versus any specific nonsurgical 
treatment.
In conclusion, in the as-treated analysis, if we 
combine the randomized and observational co-
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horts, carefully adjusting for potentially con-
founding baseline factors, patients with spinal 
stenosis without degenerative spondylolisthesis 
who underwent surgery showed significantly 
greater improvement in pain, function, satisfac-
tion, and self-rated progress than did patients 
who were treated nonsurgically.
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